Collectively, our experiments reveal an unexpected capacity of TLR3/7/9-deficient mice to induce protective T-cell-dependent immunity, which is associated with substantial changes in the tumour microenvironment, T-cell activation and tumour regression. The gene discussed is TLR3; the disease is neoplasm.